Power
Reimagined

Indication
DOVATO is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known substitutions associated with resistance to the individual components of DOVATO.

Not an actual patient.

Indication
DOVATO is indicated as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults with no antiretroviral treatment history and with no known substitutions associated with resistance to the individual components of DOVATO.

Discover Dovato

GEMINI 1 & 2 TRIALS

See trial results and 96-week long-term data

SEE LONG-TERM DATA

Read more »

RESISTANCE RESULTS

Data available through 96 weeks in treatment-naïve adult patients with HIV-1

SEE 96-WEEK DATA

Read more »

RISKS & SIDE EFFECTS

Info about the possible risks and side effects, including drug-related adverse events and rates of discontinuation

LEARN MORE

Read more »

Models not actual patients

A deeper Look at DOVATO

TV COMMERCIAL FOR DOVATO

Hear from a patient living with HIV-1 and learn more about DOVATO                

Read more »

REQUEST A ViiV REPRESENTATIVE

Have questions about DOVATO? Speak with a ViiV Representative in person

Read more »

DLLWCNT190029